Innoveren Scientific Inc. (IVRN)
Develops cell therapies to save damaged limbs and treat hard-to-cure cancers.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+0.0%
The outlook
IVRN trades at the absolute bottom of its 52-week range with no movement today. The stock sits well below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage appears sparse or absent for this micro-cap security.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$932
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—